Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Current Therapy For Mesothelioma.

Sugarbaker, Norberto, Bueno
Published 1997 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND: Diffuse malignant pleural mesotheliomas (DMPMs) are highly lethal tumors that are becoming more common. Standard management approaches have provided limited effectiveness. METHODS: The literature on management has been revised, and the authors present their data on outcomes for 120 patients treated with an aggressive trimodality approach. RESULTS: An aggressive trimodality approach including extrapleural pneumonectomy followed by chemoradiation produces low mortality and acceptable morbidity. The five-year survival rate in patients with epithelial histology and negative nodes approaches 40%. CONCLUSIONS: Nodal status and histologic subtype are major predictors for survival in patients with early DMPM. A uniformly accepted staging system would allow comparison of treatment approaches from various institutions. More effective management interventions are required.
This paper references
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.1200/JCO.1994.12.6.1156
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
V. Rusch (1994)
10.1097/00000421-198602000-00020
Cancer : Principles and Practice of Oncology
V. Devita (1982)
10.2214/AJR.159.5.1414807
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
E. Patz (1992)
General Thoracic Surgery
Thomas W. Shields (1972)
Multimodality therapy of malignant mesothelioma
DJ Sugarbaker (1996)
10.1016/S0960-7404(97)90015-3
Important advances in oncology 1996
P. Price (1997)
10.1002/1097-0142(19810601)47:11<2678::AID-CNCR2820471126>3.0.CO;2-9
Solitary fibrous tumors of the pleura: Eight new cases and review of 360 cases in the literature
M. Briselli (1981)
Projections of asbestos-related disease 1980-2009.
A. Walker (1983)
10.1093/JNCI/79.1.31
Geographic patterns for pleural mesothelioma deaths in the United States, 1968-81.
P. Enterline (1987)
10.1002/1097-0142(19861015)58:8<1699::AID-CNCR2820580820>3.0.CO;2-B
Thrombocytosis in patients with malignant pleural mesotheliomia
T. Nakano (1986)
10.1097/00063198-199707000-00011
Diseases of the pleura.
R. Light (1995)
Benign and malignant mesothelioma
KH Antman (1993)
Textbook of surgery: The biological basis of modern surgical practice
D. Sabiston (1986)
[Radiotherapy of malignant pleural mesotheliomas. Apropos of 14 cases irradiated at high doses].
F. Eschwège (1973)
Paclitaxel and carboplatin combination chemotherapy as an effective palliative treatment for malignant mesothelioma
KR Hoffman (1996)
[Chances and results of surgery of malignant mesothelioma of the pleura (author's transl)].
H. Wörn (1974)
10.1016/S0022-5223(96)70342-2
The importance of surgical staging in the treatment of malignant pleural mesothelioma.
V. Rusch (1996)
SV40 induces mesotheliomas in hamsters.
C. Cicala (1993)
10.Diffuse Malignant Mesotheliomaの1例(第721回 千葉医学会例会・第19回 肺癌研究施設例会)
光永 伸一郎 (1985)
Mesothelioma. In: Sabiston DC Jr, ed
DJ Sugarbaker (1996)
10.1378/chest.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
V. Rusch (1996)
Simian virus 40-like DNA sequences in human pleural mesothelioma.
M. Carbone (1994)
10.1093/JNCI/78.6.1053
Demographic patterns for mesothelioma in the United States.
R. Connelly (1987)
10.1200/JCO.1993.11.6.1172
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.
D. Sugarbaker (1993)
10.1097/00000658-199609000-00005
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.
D. Sugarbaker (1996)
Projections of asbestosrelated disease 19802009
AM Walker (1983)
10.1016/0360-3016(82)90379-0
Radiation therapy in the management of patients with mesothelioma.
W. Gordon (1982)
Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy.
K. Allen (1994)
10.1016/S0022-5223(19)36577-8
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
V. Rusch (1991)
Surgical treatment of malignant mesothelioma
JP Garcia (1997)
Evidence for and implications of SV40-like sequences in human mesotheliomas.
H. Pass (1996)
Therapeutic modalities in malignant pleural mesothelioma
AP Chahinian (1983)
Thoracic surgery : surgical management of pleural diseases
J. Deslauriers (1990)
New concepts in the staging of mesotheliomas
VW Rusch (1990)
Mastery of Cardiothoracic Surgery
L. R. Kaiser (1998)
10.1055/S-0028-1102795
Möglichkeiten und Ergebnisse der chirurgischen Behandlung des malignen Pleuramesothelioms
H. Wörn (1974)



This paper is referenced by
10.1002/cncr.20315
Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma
P. Hollen (2004)
Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
P. Jänne (2002)
10.1007/978-3-642-18536-6_89
Ein Bildverarbeitungssystem für die automatisierte Vermessung und quantitative Verlaufsdokumentation von pleuralen Verdickungen
S. Vogel (2004)
10.1016/S0169-5002(99)00030-6
Ifosfamide in malignant mesothelioma: a phase II study.
M. Andersen (1999)
10.1016/S1010-7940(03)00376-2
Treatment of mesothelioma in Bloemfontein, South Africa.
W. de Vries (2003)
Mesotelioma pleural maligno Malignant Pleural Mesothelioma
Mónica Edith Serna-Camacho (2012)
Malignant Pleural Mesothelioma Inhibition of Epidermal Growth Factor Receptor Signaling in Updated
P. A. Jänne (2002)
10.1093/CARCIN/23.6.1017
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma.
G. Gordon (2002)
10.1177/000331970105200505
Percutaneous Balloon Pericardiotomy for Patients with Malignant Pericardial Effusion Including Three Malignant Pleural Mesotheliomas
K. Övünç (2001)
INVITED REVIEW SERIES: COMPLICATIONS IN LUNG PROCEDURES
P. Lee (2009)
Diffuse malignant mesothelioma of the pleural space and its management.
L. Zellos (2002)
10.1053/j.semtcvs.2009.07.003
Making the case for molecular staging of malignant pleural mesothelioma.
R. Bueno (2009)
10.1016/J.ATHORACSUR.2004.05.007
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.
R. Bueno (2004)
10.1186/1471-2407-11-169
Genes Associated With Prognosis After Surgery For Malignant Pleural Mesothelioma Promote Tumor Cell Survival In Vitro
G. Gordon (2010)
10.1016/S0169-5002(98)00072-5
Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma.
A. Purohit (1998)
10.1002/path.2120
Inhibitor of apoptosis proteins are regulated by tumour necrosis factor‐α in malignant pleural mesothelioma
G. Gordon (2007)
10.1093/JJCO/HYE016
Nodular thickening of interlobar fissures: an early manifestation of malignant mesothelioma: a case report.
S. Bandoh (2001)
10.1378/CHEST.116.SUPPL_3.444S
Mesothelioma clinical presentation.
R. Bueno (1999)
10.1007/3-540-32137-3_3
3D-Erkennung, Analyse und Visualisierung pleuraler Verdickungen in CT-Daten
P. Jäger (2006)
10.1016/S1547-4127(04)00113-6
Genetics of malignant pleural mesothelioma: molecular markers and biologic targets.
R. Bueno (2004)
10.1007/S00268-003-7159-5
Radical Surgery for Mesothelioma: How Can We Obtain Evidence?
T. Treasure (2003)
10.1016/J.HOC.2005.09.011
Multimodality treatments in the management of malignant pleural mesothelioma: an update.
R. Bueno (2005)
10.1188/03.CJON.431-437
Diffuse malignant pleural mesothelioma: Part I. An overview of diagnosis, staging, and treatment options.
C. Brueggen (2003)
10.1007/s00280-007-0500-1
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma
G. Gordon (2007)
10.1016/b978-0-323-37706-5.50120-7
Malignant Pleural Mesothelioma
Mónica Edith Serna-Camacho (2016)
10.1067/MTC.2001.111176
The α folate receptor is highly activated in malignant pleural mesothelioma
R. Bueno (2001)
10.1007/s00520-005-0837-0
Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso
P. Hollen (2005)
Malignant mesothelioma of the pleural space.
R. Flores (2000)
10.1007/978-88-470-0467-2_26
I tumori del polmone
L. Portalone (2006)
Malignant mesothelioma of the pleural space.
Grondin Sc (1999)
10.1111/j.1440-1843.2009.01653.x
Management of complications of minimally invasive thoracic surgery
M. Hsin (2010)
Semantic Scholar Logo Some data provided by SemanticScholar